Evidence map›Paper›PMID 39446237›Full record

ReviewBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2025

Metallic nanoparticles: a promising novel therapeutic tool against antimicrobial resistance and spread of superbugs.

Naheem Adekilekun Tijani, Joseph Hokello, Emmanuel Eilu, Saheed Adekunle Akinola, Abdullateef Opeyemi Afolabi, Danladi Makeri, Tonny Wotoyitide Lukwago, Irene M Mutuku, Alex Mwesigwa, Andrew Baguma and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Antimicrobial synergism of silver and zinc oxide nanoparticles with antibiotics against clinical isolate of Cutibacterium acnes.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Alkanna tinctoria extract-mediated biomass synthesis of Ag-ZnO nanoparticles: characterization, antimicrobial and antibiofilm activities.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Naheem Adekilekun TijaniDepartment of Microbiology and Immunology, Kampala International University, Western Campus, Bushenyi, Uganda.
Joseph HokelloDepartment of Biology, Faculty of Science and Education, Busitema University, Tororo, Uganda.
Emmanuel EiluDepartment of Microbiology and Immunology, Kampala International University, Western Campus, Bushenyi, Uganda.
Saheed Adekunle AkinolaFood Security and Safety Focus Area, Faculty of Natural and Agricultural Sciences, North-West University, Mmabatho, South Africa.
Abdullateef Opeyemi AfolabiDepartment of Microbiology and Immunology, Kampala International University, Western Campus, Bushenyi, Uganda.
Danladi MakeriDepartment of Microbiology and Immunology, Kampala International University, Western Campus, Bushenyi, Uganda.
Tonny Wotoyitide LukwagoDepartment of Pharmacology and Toxicology, Kampala International University, Western Campus, Bushenyi, Uganda.
Irene M MutukuDepartment of Microbiology, School of Medicine, Kabale University, Kabale, Uganda.
Alex MwesigwaDepartment of Microbiology, School of Medicine, Kabale University, Kabale, Uganda.
Andrew BagumaDepartment of Microbiology, School of Medicine, Kabale University, Kabale, Uganda.
Ismail Abiola AdebayoDepartment of Microbiology, School of Medicine, Kabale University, Kabale, Uganda. iaadebayo@kab.ac.ug.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, antimicrobial resistance (AMR) has become an alarming threat to global health as notable increase in morbidity and mortality has been ascribed to the emergence of superbugs. The increase in microbial resistance because of harboured or inherited resistomes has been complicated by the lack of new and effective antimicrobial agents, as well as misuse and failure of existing ones. These problems have generated severe and growing public health concern, due to high burden of bacterial infections resulting from scarce financial resources and poor functioning health systems, among others. It is therefore, highly pressing to search for novel and more efficacious alternatives for combating the action of these super bacteria and their infection. The application of metallic nanoparticles (MNPs) with their distinctive physical and chemical attributes appears as promising tools in fighting off these deadly superbugs. The simple, inexpensive and eco-friendly model for enhanced biologically inspired MNPs with exceptional antimicrobial effect and diverse mechanisms of action againsts multiple cell components seems to offer the most promising option and said to have enticed many researchers who now show tremendous interest. This synopsis offers critical discussion on application of MNPs as the foremost intervening strategy to curb the menace posed by the spread of superbugs. As such, this review explores how antimicrobial properties of the metallic nanoparticles which demonstrated considerable efficacy against several multi-drugs resistant bacteria, could be adopted as promising approach in subduing the threat of AMR and harvoc resulting from the spread of superbugs.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsDrug Resistance, BacterialMetal NanoparticlesAnimalsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAntibioticsAntimicrobial resistanceApplicationMetallic nanoparticlesPathogenic bacteriaSuperbugs

Identifiers

PMID39446237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.